QSAR and 3D QSAR in drug design .2. Applications and problems

被引:171
作者
Kubinyi, H
机构
[1] Drug Design, ZHV/W-A30, BASF AG
关键词
D O I
10.1016/S1359-6446(97)01084-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
QSAR already plays an important role in lead structure optimization and it can be predicted that QSAR methods will become essential for handling the huge amount of data associated with combinatorial chemistry. 3D QSAR has already been successfully applied to many data sets of enzyme and receptor ligands. The theory and methodology of these approaches were outlined in Part 1 of this article, published in the November issue. In the second part of this two-part review, the author explains the applications of these methods and addresses the associated problems.
引用
收藏
页码:538 / 546
页数:9
相关论文
共 43 条
[1]  
BARONI M, 1992, QUANT STRUCT-ACT REL, V12, P9
[2]   STRUCTURE ACTIVITY RELATIONSHIPS OF DIHYDROFOLATE-REDUCTASE INHIBITORS [J].
BLANEY, JM ;
HANSCH, C ;
SILIPO, C ;
VITTORIA, A .
CHEMICAL REVIEWS, 1984, 84 (04) :333-407
[3]  
BLANKLEY CJ, 1996, STRUCTURE PROPERTY C, P111
[4]  
BOHM HJ, 1996, ANGEW CHEM, V108, P2750
[5]  
BOHM HJ, 1996, ANGEW CHEM INT EDIT, V35, P258
[6]  
BOHM HJ, 1996, WIRKSTOFFDESIGN, P363
[7]  
BOYD DB, 1990, REV COMPUTATIONAL CH, V1, P355
[8]  
Camenisch G, 1996, Pharm Acta Helv, V71, P309, DOI 10.1016/S0031-6865(96)00031-3
[9]  
CRAMER RD, 1988, QUANT STRUCT-ACT REL, V7, P91
[10]   CROSS-VALIDATION, BOOTSTRAPPING, AND PARTIAL LEAST-SQUARES COMPARED WITH MULTIPLE-REGRESSION IN CONVENTIONAL QSAR STUDIES [J].
CRAMER, RD ;
BUNCE, JD ;
PATTERSON, DE ;
FRANK, IE .
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1988, 7 (01) :18-25